Starting with SCA1, Park et al. (2020) assessed white matter changes via DTI in both symptomatic SCA1 patients and patients who were carriers of the ATXN1 mutation but were not yet exhibiting ataxia symptoms (“preataxic”) [32]. This evidence concerns the gene ATXN1 and Ataxia.